There was a significant negative correlation between CD4 counts and the aTreg frequencies in samples from treated patients during the follow-up (Figure 3E), but not in the samples from CLL patients with advanced disease at the start of therapy. Here, CD4 is linked to B-cell chronic lymphocytic leukemia.